We demonstrated that a genetically determined portion of S100A8/A9 was associated with post-AMI HF risk, suggesting that S100A8/A9 acts as an intermediate causal phenotype in post-AMI HF. This evidence concerns the gene S100A8 and hydrops fetalis.